| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.153 | 2.131 | 2.095 | 2.056 | 2.016 | 1.978 | 1.934 | 1.940 | -18.156 | 0 |
| Gross Profit/Loss - EUR | -2.153 | -2.131 | -2.095 | -2.056 | -2.016 | -1.978 | -1.934 | -1.940 | 18.156 | 0 |
| Net Profit/Loss - EUR | -2.153 | -2.131 | -2.095 | -2.056 | -2.016 | -1.978 | -1.934 | -1.940 | 18.156 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gavrimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 69.962 | 67.118 | 63.887 | 60.659 | 57.467 | 54.400 | 51.259 | 49.478 | 0 | 0 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -61.489 | -62.993 | -64.021 | -64.903 | -65.662 | -66.396 | -66.858 | -69.005 | -50.640 | -50.357 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 131.451 | 130.110 | 127.909 | 125.561 | 123.129 | 120.795 | 118.116 | 118.483 | 50.640 | 50.357 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Gavrimed S.r.l.